SCHEMBL19924329

SCHEMBL19924329

CCOC(=O)C(CSSC(C)(C)C)NC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ METAP2 P50579 1/20 0.38
▸ METAP1 P53582 1/20 0.38
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ CAD P27708 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ PKM P14618 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2953811 0.87 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL2953812 0.87 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL2953807 0.87 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL21086900 0.85 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL21086903 0.82 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL19216892 0.82 ITGB1 (0.43) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL11773441 0.81 SMN1; SMN2 (0.46) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL11773446 0.81 SMN1; SMN2 (0.46) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL21086976 0.80 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL13138368 0.80 SMN1; SMN2 (0.43) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3503730-B1 COMPOSITIONS COMPRISING REVERSIBLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF DICERNA PHARMACEUTICALS INC (US) 2023-09-27 — — EP disclosed
WO-2018039364-A1 COMPOSITIONS COMPRISING REVERSIBLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2018-03-01 — — WO disclosed
Send feedback